Efficacy of a tailored moisturizer for reducing chemotherapy-induced skin dryness in breast cancer patients: A randomized controlled clinical trial

Danbee Kang; Nayeon Kim; Young Hyuck Im; Yeon Hee Park; Ji Yeon Kim; Hyeokgon Park; Eunjoo Kim; Di Zhao; Eliseo Guallar; Jin Seok Ahn; Juhee Cho

doi:10.1016/j.jaad.2021.10.047

Efficacy of a tailored moisturizer for reducing chemotherapy-induced skin dryness in breast cancer patients: A randomized controlled clinical trial

J Am Acad Dermatol. 2022 Oct;87(4):858-860. doi: 10.1016/j.jaad.2021.10.047. Epub 2021 Oct 30.

Authors

Danbee Kang¹, Nayeon Kim², Young Hyuck Im³, Yeon Hee Park³, Ji Yeon Kim³, Hyeokgon Park⁴, Eunjoo Kim⁴, Di Zhao⁵, Eliseo Guallar⁶, Jin Seok Ahn⁷, Juhee Cho⁸

Affiliations

¹ Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
² Cancer Education Center, Samsung Comprehensive Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
³ Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
⁴ Skin Research Institute, AMOREPACIFIC R&D Center, Yongin, Republic of Korea.
⁵ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
⁶ Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
⁷ Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: jinseok.ahn@samsung.com.
⁸ Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Cancer Education Center, Samsung Comprehensive Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Electronic address: jcho@skku.edu.

PMID: 34728262
DOI: 10.1016/j.jaad.2021.10.047

No abstract available

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents* / adverse effects
Breast
Breast Neoplasms* / drug therapy
Emollients / therapeutic use
Female
Humans
Treatment Outcome

Substances

Antineoplastic Agents
Emollients

Associated data

CRiS/KCT0001372